 |
|
|
| |
PREVALENCE AND RISK FACTORS FOR HCC AMONG PATIENTS WITH CURENT AND PRIOR HCV IN A REAL-WORLD COHORT IN THE POST-DAA ERA
|
| |
| |
AASLD 2024 Nov 15-19 San Diego
M. Sedki1,2, J. Price1, G. Intinarelli, M. Helle1, T. Toliver1, and R. Fox1
1. University of California San Francisco, San Francisco, California, USA
2. Stanford University School of Medicine, Palo Alto, California, USA
|
| |
|
|
|
|
|
